Policies and measures implemented to reduce the impact of international sanctions on Iran's pharmaceutical sector.
Autorzy:
Emami F; School of Pharmacy, Tehran Medical Science, Islamic Azad University, Tehran, I.R. Iran. CheraghaliAM; Department of Pharmacology, Faculty of Pharmacy, Baqiyatallah University of Medical Sciences, Tehran, I.R. Iran.
Pokaż więcej
Źródło:
Research in pharmaceutical sciences [Res Pharm Sci] 2022 Apr 18; Vol. 17 (3), pp. 274-283. Date of Electronic Publication: 2022 Apr 18 (Print Publication: 2022).
The Association of Age, Sex, and RT-PCR Results with the Lymphocyte and Neutrophil Counts in SARS-CoV-2 Infection: A Cross-sectional Analysis of 1450 Iranian Patients with COVID-19.
Autorzy:
Bashash D; Department of Hematology and Blood Banking, School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran. David_. Abolghasemi H; Applied Microbiology Research Center, Systems Biology and Poisonings Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran. . Naseri P; Research Center for Social Determinants of Health, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran. . CheraghaliAM; Faculty of Pharmacy, Baqiyatallah University of Medical Sciences, Tehran, Iran. . Soltanpoor MJ; Clinical and Molecular Laboratory, Baqiyatallah Hospital, Baqiyatallah University of Medical Sciences, Tehran, Iran. . Imani Fooladi AA; Applied Microbiology Research Center, Systems Biology and Poisonings Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran. .
Management of COVID-19 Virus Infection by Convalescent Plasma.
Autorzy:
CheraghaliAM; Faculty of Pharmacy, Baqiyatallah University of Medical Sciences, Tehran, Iran. . Abolghasemi H; Faculty of Medicine, Baqiyatallah University of Medical Sciences, Tehran, Iran. . Eshghi P; Faculty of Medicine, Shahid Beheshti University of Medical Sciences and Iran Blood Transfusion Organization; Tehran, Iran. .
CheraghaliAM; School of Pharmacy, Baqiyatallah University of Medical Sciences and Pharmaceutical Management and Economic Research Center, Tehran, IR Iran.
Health-Related Quality of Life and Health Utility Values in Beta Thalassemia Major Patients Receiving Different Types of Iron Chelators in Iran.
Autorzy:
Seyedifar M; Pharmaceutical Management and Economics Research Center, Tehran University of Medical Sciences, Tehran, Iran. Dorkoosh FA; Department of Pharmacoeconomics and Pharmaceutical Administration, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran. Hamidieh AA; Hematology-Oncology and Stem Cell Transplantation Research Center, Tehran University of Medical Sciences, Tehran, Iran. Naderi M; Department of Pediatrics Hematology-Oncology, Ali-Ebne Abitaleb Hospital Research Center for Children and Adolescent Health [RCCAH], Zahedan University of Medical Sciences, Zahedan, Iran. Karami H; Thalassemia Research Center, Hemoglobinopathy Institute, Mazandaran University of Medical Sciences, Sari, Iran. Karimi M; Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. Fadaiyrayeny M; Hematology-Oncology and Stem Cell Transplantation Research Center, Tehran University of Medical Sciences, Tehran, Iran. Musavi M; Department of Pediatrics Hematology-Oncology, Ali-Ebne Abitaleb Hospital Research Center for Children and Adolescent Health [RCCAH], Zahedan University of Medical Sciences, Zahedan, Iran. Safaei S; MSc Student of Nursing, Islamic Azad University, Isfahan (Khorasgan) Branch, Isfahan, Iran. Ahmadian-Attari MM; Department of Traditional Medicine, Medicinal Plants Research Center of Barij, Kashan, Iran. Hadjibabaie M; Research Center for Rational Use of Drugs, Tehran University of Medical Sciences, Tehran, Iran; Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran. CheraghaliAM; Faculty of Pharmacy, University of Baqiyatallah Medical Sciences, Tehran, Iran. Akbari Sari A; Department of Health Management and Economics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Cost-Effectiveness Analysis of Biogeneric Recombinant Activated Factor VII (AryoSeven™) and Activated Prothrombin Complex Concentrates (FEIBA™) to Treat Hemophilia A Patients with Inhibitors in Iran.
Autorzy:
Golestani M; School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran, Iranian Center of Excellence in Health Management, Road Traffic Injury Research Center, Tabriz University of Medical Sciences,Tabriz, Iran. Eshghi P; Pediatric Congenital Hematologic Disorders Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Rasekh HR; School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran. CheraghaliAM; School of Pharmacy, University of Baqiyatallah Medical Sciences, Tehran, Iran. Salamzadeh J; School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Naderi M; Genetics of Non- communicable Disease Research Center, Zahedan University of Medical Sciences, Zahedan, Iran. Managhchi MR; Tehran University of Medical Sciences, Thrombosis and Hemostasis Research Center, Tehran, Iran. Hoorfar H; Inherited Blood Disorders Clinic Seiedshohada Hospital, Isfahan University of Medical Sciences, Isfahan, Iran. Toogeh GR; Tehran University of Medical Sciences, Thrombosis and Hemostasis Research Center, Tehran, Iran. Imani A; Iranian Center of Excellence in Health Management, Health Services Management Research Center, Faculty of Management and Medical Informatics, Tabriz University of Medical Sciences, Tabriz, Iran. Khodayari MT; Tabriz University of Medical Sciences, Tabriz, Iran. j Iranian Ministry of Health, Tehran, Iran. Habibpanah B; Pediatric Congenital Hematologic Disorders Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Hantooshzadeh R; Tehran University of Medical Sciences, Thrombosis and Hemostasis Research Center, Tehran, Iran.
Cost effectiveness of Iran national plasma contract fractionation program.
Autorzy:
CheraghaliAM; High Institute for Research and Education on Transfusion Medicine, Iran Blood Transfusion Organization and Faculty of Medicine, University of Baqiyatallah Medical Sciences, Tehran, Iran. .
Economical impact of plasma fractionation project in Iran on affordability of plasma-derived medicines.
Autorzy:
CheraghaliAM; Iranian Blood Transfusion Organization Research Center and Chemical Injury Research Center, University of Baqiyatallah Medical Sciences, Tehran, Iran. Cheraghali@ibto.ir Aboofazeli R
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies